Specialities

Radiation science

Speciality Keywords

Abdominal Radiology, Hepatocellular Carcinoma, CT, MRI

Research Themes

Books

Papers

• 　Gadoxetic acid enhanced MR imaging for hepatocellular carcinoma: molecular and genetic background.　Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, Inoue D, Ogi T, Yoshida K, Gabata T.　30　6　3438-3447　2020
• 　Gadoxetic acid-enhanced magnetic resonance imaging reflects co-activation of β-catenin and hepatocyte nuclear factor 4α in hepatocellular carcinoma.　Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, Minami T, Inoue D, Yoshida K, Yamashita T, Yamashita T, Kaneko S, Takamura H, Ohta T, Ikeda H, Sato Y, Nakanuma Y, Harada K, Kita R, Gabata T.　Hepatology Research　48　2　205-216　2017
• 　Differentiation between hepatocellular carcinoma showing hyperintensity on the hepatobiliary phase of gadoxetic acid enhanced MRI and focal nodular hyperplasia by CT and MRI　Kitao A, Matsui O, Yoneda N, Kita R, Kozaka K, Kobayashi S, Gabata T.　American Journal of Roentgenology　211　2　347-357　2018
• 　Hepatocellular Carcinoma with β-Catenin Mutation: Imaging and Pathologic Characteristics.　Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Sanada J, Koda W, Minami T, Inoue D, Yoshida K, Yamashita T, Yamashita T, Kaneko S, Takamura H, Ohta T, Ikeda H, Nakanuma Y, Kita R, Gabata T.　Radiology　275　3　708-17　2015
• 　Hypervascular hepatocellular carcinoma: correlation between biologic features and signal intensity on gadoxetic acid-enhanced MR images.　Kitao A, Matsui O, Yoneda N, Kozaka K, Kobayashi S, Koda W, Gabata T, Yamashita T, Kaneko S, Nakanuma Y, Kita R, Arii S　Radiology　265　780-9　2012

show all

Conference Presentations

• Imaging, pathological and molecular characteristics of programmed cell death ligand 1 positive hepatocellular carcinoma(conference：Radiological Society of North America 2023)(2023/11/26)
• 肝細胞癌の個別化診療におけるGd-EOB-DTPA造影MRIの役割(conference：第51回日本磁気共鳴学会大会)(2023/09/23)
• Radiogenimics in hepatocellular carcinoma for prediction of prognosis.(conference：International Liver Cancer Association 2023)(2023/09/09)
• 肝細胞癌の薬物療法時代における画像診断の役割(conference：第26回奈良県画像診断・IVR研究会)(2023/08/04)
• 肝細胞癌の画像バイオマーカーとしてのGd-EOB-DTPA造影MRIの役割: Up to date(conference：第59回日本肝癌研究会)(2023/07/28)

show all

Others

Arts and Fieldwork

Patent

Theme to the desired joint research

Grant-in-Aid for Scientific Research

○「肝細胞癌のradiomicsに基づく薬物治療効果予測」(2021-2024)　
○「肝細胞癌の分子・遺伝子的亜分類に基づいたradiogenomics」(2017-2019)　
○「β-catenin変異型肝細胞癌のGd-EOB-DTPA造影MRI所見」(2014-2015)　
○「肝細胞癌のGd-EOB-DTPA造影MRIによるsubtype分類」(2012-2013)　

Competitive research funding,Contribution

Collaborative research,Consignment study

Classes (Bachelors)

○Practical Clinical Technology(2024)
○Radiological Mechinery Experiment 2(2024)
○Physiology Laboratory 2(2024)

Classes (Graduate Schools)